Related Experiment Video
Updated: Dec 16, 2025

09:43
Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
2.3K
COVID-19: A collision of complement, coagulation and inflammatory pathways.
Anoop J Chauhan1,2,3, Laura J Wiffen1,3, Thomas P Brown1,3
1Research and Innovation, Queen Alexandra Hospital, Portsmouth, UK.
Journal of Thrombosis and Haemostasis : JTH
|July 2, 2020
Summary
COVID-19 causes inflammation and clotting by activating the complement system, particularly C5a. Blocking C5a may treat severe COVID-19 by reducing harmful inflammatory responses and organ damage.
Area of Science:
- Immunology
- Pathophysiology
- Virology
Background:
- COVID-19 presents with hypercoagulability and inflammation, potentially involving the complement system.
- Similarities to atypical hemolytic uremic syndrome (aHUS) suggest complement pathway involvement in COVID-19 pathogenesis.
Purpose of the Study:
- To review the role of the complement pathway, specifically C5a, in severe viral infections like COVID-19.
- To explore C5a as a potential therapeutic target for COVID-19 treatment.
Main Methods:
- Literature review focusing on the complement system's role in COVID-19 pathophysiology.
- Analysis of C5a's function in inflammation, coagulation, and organ injury.
Main Results:
- C5a drives a cytokine storm, leading to lung injury, immune exhaustion, and a pro-coagulant state.
- Complement activation and microvascular thrombi are evident in fatal COVID-19 cases, particularly in the lungs and kidneys.
Conclusions:
- Aberrations in the complement pathway, especially C5a, are implicated in severe COVID-19.
- C5 blockade shows promise as a therapeutic strategy, supported by animal studies and aHUS treatment data.
More Related Videos
Related Concept Videos
Complement System
8.5K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
8.5K
Extrinsic and Intrinsic Pathways of Hemostasis
11.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.3K
Antimicrobial Proteins
12.8K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.8K
Coagulation
9.3K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.3K
Coagulation
1.1K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.1K
Inflammation
61.0K
Overview
61.0K

